DiviDrip · VRAX

VRAX — Virax Biolabs Group Limited Ordinary Shares

VRAX is Virax Biolabs Group Limited Ordinary Shares (Healthcare) — a non-dividend-paying stock. Trading at $2.63. Market cap: $2M. Capital Quality Rank: 31/100 — Stagnant mediocrity.

Stock snapshot

Price$2.63
Market cap$2M
SectorHealthcare
ExchangeXNAS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)31 / 100 · Stagnant mediocrity
ROIC (TTM)-234.6%
Revenue CAGR (3y)13.2%
Shareholder buyback yield-30.00%
Altman Z-score zoneDistress

About VRAX

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

Listed2022Employees26SectorHealthcareWebsiteviraxbiolabs.com

Related non-dividend companies

Other non-dividend stocks investors research alongside VRAX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is VRAX's current stock price?

VRAX (Virax Biolabs Group Limited Ordinary Shares) is currently trading at $2.63.

Does VRAX pay a dividend?

VRAX (Virax Biolabs Group Limited Ordinary Shares) does not currently pay a regular dividend.

What is VRAX's Capital Quality Rank?

VRAX has a Capital Quality Rank of 31/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track VRAX in DiviDrip

Add VRAX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow